Standard Treatment group

OTHER3 trials

Sponsors

University of Sao Paulo General Hospital, Second Xiangya Hospital of Central South University, Cytori Therapeutics

Conditions

Hand DysfunctionHeart FailureHeart TransplantImmune Checkpoint Inhibitors (ICIs)Non Small Cell Lung CancerSystemic Sclerosis (SSc)

Phase 2

ctDNA-MRD Guided Escalation of Ivonescimab and Docetaxel in Advanced NSCLC With Long-Term Responses to First-line Immunotherapy (CR1STAL-Adaptive)

RecruitingNCT06951646

Second Xiangya Hospital of Central South UniversityImmune Checkpoint Inhibitors (ICIs), Non Small Cell Lung Cancer

Start: 2026-03-10End: 2030-06-01Target: 70Updated: 2026-03-09

Unknown Phase

Effect of Resistance Training in Patients on the Waiting List for Heart Transplant

RecruitingNCT06426173

University of Sao Paulo General HospitalHeart Failure, Heart Transplant

Start: 2024-06-18End: 2027-06-30Target: 50Updated: 2026-06-22

Safety and Efficacy of Adipose-Derived Regenerative Cells (ADRCs) for Improving Hand Dysfunction in Systemic Sclerosis

RecruitingNCT07360808

Cytori TherapeuticsHand Dysfunction, Systemic Sclerosis (SSc)

Start: 2025-12-31End: 2027-12-31Target: 48Updated: 2026-01-22